Related Experiment Video
Updated: Aug 6, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression
D Zhang1, S Vuocolo, V Masciullo
1Department of Microbiology & Immunology, Temple University School of Medicine, 3400 North Broad Street, Philadelphia, Pennsylvania, PA 19140, USA.
Abstract:
We have examined the effect of all-trans-retinoic acid (RA) on cell cycle gene expression in RA sensitive CA-OV3 and RA resistant SK-OV3 ovarian carcinoma cell lines. Gene expression was analysed by multiprobe RNAse protection, Western blotting and in vitro kinase assays. No differences were observed between RA sensitive and RA resistant ovarian carcinoma cells in the levels of expression of many cell cycle genes including cyclin A, B and E, cdk 2,4 and 6, E2F-1, E2F-2, E2F-3, E2F-4, E2F-5, DP-1 and DP-2. However, RA sensitive CA-OV3 cells expressed higher levels of p53, p27, p21, and p16 compared to RA resistant SK-OV3 cells. In addition, RA treatment of CA-OV3 cells resulted in a significant decrease in hyperphosphorylated RB and RB-2/p130 and corresponding significant increases in the levels of hypophosphorylated and/or partially phosphorylated RB-2/p130 protein and hypophosphorylated RB. Also, RA treatment increased expression of the cdk inhibitor p27 and decreased activity of cdk 2, cdk 4 and cdk 6. Finally, amounts of p27-cyclin E and RB-2/p130-E2F4 complexes were found to increase in CA-OV3 cells growth arrested by RA. These results suggest that the pocket protein pathways are critical targets for retinoid suppression of ovarian carcinoma cell growth.
Insights
All-trans-retinoic acid (RA) affects ovarian carcinoma cell growth by altering cell cycle gene expression. RA-sensitive cells show increased levels of tumor suppressors and cell cycle inhibitors, suggesting pocket protein pathways are key targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ovarian carcinoma is a significant health concern.
- Understanding the mechanisms of retinoid action in cancer is crucial for developing new therapies.
Purpose of the Study:
- To investigate the effect of all-trans-retinoic acid (RA) on cell cycle gene expression in RA-sensitive and RA-resistant ovarian carcinoma cell lines.
- To identify key molecular targets of RA in suppressing ovarian cancer cell growth.
Main Methods:
- Gene expression analysis using multiprobe RNAse protection assays.
- Protein level analysis via Western blotting and in vitro kinase assays.
- Assessment of protein-protein interactions, including p27-cyclin E and RB-2/p130-E2F4 complexes.
Main Results:
- RA-sensitive cells (CA-OV3) exhibited higher expression of p53, p27, p21, and p16 compared to RA-resistant cells (SK-OV3).
- RA treatment decreased hyperphosphorylated Retinoblastoma protein (RB) and RB-2/p130, while increasing hypophosphorylated forms.
- RA treatment elevated cyclin-dependent kinase (CDK) inhibitor p27 expression and reduced CDK 2, 4, and 6 activity.
Conclusions:
- Pocket protein pathways are critical targets for retinoid-mediated suppression of ovarian carcinoma cell growth.
- Differential expression of cell cycle regulators and their interactions underlies retinoid sensitivity in ovarian cancer.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

